Natco Pharma is a Hyderabad-based pharma. For more information, please read https://www.thehealthsite.com/topics/natco/ Experts believe that this case will set a ...

Natco Pharma on April 8 said that the launch of its generic version of Roche Pharma's patented drug, Risdiplam, is contingent upon the successful outcome in a patent infringement case.

Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...

A two-judge bench of Delhi High Court on Wednesday refrained Natco Pharma from launching the generic version of Swiss drugmaker Roche Pharma's patented drug Risdiplam until the hearing on April 2.

Drugmaker Natco Pharma on Tuesday said it intends to launch its generic version of spinal muscular atrophy drug Risdiplam only after and subject to successful clarity from the Appellate Bench of ...

Natco Pharma Q3 Results: NATCO Pharma Ltd reported a sharp decline of 37.75 percent in consolidated net profit for the December quarter, primarily impacted by a downturn in formulations exports.

Learn about Natco Pharma Ltd. in Hyderabad, Telangana.Find comprehensive contact details, including phone numbers and email addresses, and get directions to the location. If you own or are ...

Natco Pharma has decided to price Risdiplam, indicated for the treatment of rare genetic disorder Spinal Muscular Atrophy (SMA), at₹15,900. In an update on the legal proceedings on the ...